If you miss your scheduled day, inject as soon as you remember, then resume your regular weekly schedule from that new date
Without progressive overload, your body has no reason to maintain muscle mass
Trial Metric Retatrutide 12mg (TRIUMPH-4) Semaglutide 2.4mg (STEP 1) Mean Weight Loss 28.7% at 68 weeks 14.9% at 68 weeks Mechanism Triple agonist (GLP-1/GIP/GCGR) Single agonist (GLP-1) FDA Status Phase 3 (investigational) Approved (Wegovy) Dosing Weekly subcutaneous Weekly subcutaneous Common Adverse Events GI (nausea, vomiting, diarrhea), dysesthesia GI (nausea, vomiting, diarrhea) Important caveat: These results come from different trial populations and study designs
Average weight loss: 2-5% of body weight Form: Daily oral tablet Best for: Patients with metabolic syndrome, prediabetes, or PCOS seeking affordable support with a long safety record Metformin is best known as a type 2 diabetes medication, but it is also commonly used off-label for metabolic syndrome, insulin resistance, and weight support
Endogenous GLP-1 levels have been shown to be lower in the follicular phase compared with the luteal phase (27)
Sandi : That is so important
